Nanomi's pioneering approach in drug delivery has set new benchmarks in the industry, and this award serves as a motivation to continue its mission to revolutionize healthcare
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
Dimethyl Fumarate Modified Release Capsules are indicated for the treatment of relapsing forms of multiple sclerosis
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
Alkem Medtech to acquire 100% stake of Bombay Ortho
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
Overall investment in the US facility is estimated around US$50 million
This e-commerce platform is launched as a hyperlocal model
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Subscribe To Our Newsletter & Stay Updated
